Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2000
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2373628A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
12/21/2000CA2370405A1 Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch
12/20/2000EP1061136A2 A sample preparation method and a sample preparation apparatus for DNA analysis
12/20/2000EP1061135A2 Methods and oligonucleotides for detecting nucleic acid sequence variations
12/20/2000EP1061134A2 Oligonucleotides for amplification and detection of hemochromatosis genes
12/20/2000EP1061130A1 Rna polymerase transcription promoters and method for determining base sequence
12/20/2000EP1061128A1 Method and device for carrying out high throughput biochemical reactions
12/20/2000EP1061085A2 Synthetic catalytic oligonucleotides
12/20/2000EP1060271A2 Oligonucleotides for the amplification and detection of epstein barr virus (ebv) nucleic acid
12/20/2000EP1060270A1 Mass spectrometric methods for biomolecular screening
12/20/2000EP1060269A1 Production and use of normalized dna libraries
12/20/2000EP1060268A2 Methods for identifying polycationic, peptide-like compounds with antibacterial activity
12/20/2000EP1060267A1 Methods for detecting, selecting and cloning agents that degrade or promote degradation of dna
12/20/2000EP1060264A1 Dideoxy dye terminators
12/20/2000EP1060261A1 Poly zinc finger proteins with improved linkers
12/20/2000EP1060260A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060258A1 Baculovirus expression system and method for high throughput expression of genetic material
12/20/2000EP1060257A1 Method for the induction of pathogen resistance in plants
12/20/2000EP1060256A1 Novel sphingosine-1 phosphate lyase
12/20/2000EP1060255A2 Highly crystalline urokinase
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060253A2 Modified forms of pullulanase
12/20/2000EP1060252A2 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
12/20/2000EP1060251A2 Phosphodiesterase 10
12/20/2000EP1060250A1 Modification of fatty acid metabolism in plants
12/20/2000EP1060249A1 Epitope peptides immunogenic against streptococcus pneumoniae
12/20/2000EP1060248A1 Lectomedin materials and methods
12/20/2000EP1060247A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2000EP1060246A2 Method for selecting ribozymes which are capable of covalently modifying the ribonucleic acids on 2'-oh-groups in trans
12/20/2000EP1060245A2 Human spinal cord cell lines and methods of use therefor
12/20/2000EP1060243A1 Embryonic or stem-like cell lines produced by cross-species nuclear transplantation
12/20/2000EP1060194A1 Enhancing the circulating half-life of antibody-based fusion proteins
12/20/2000EP1060193A2 Cd147 binding molecules as therapeutics
12/20/2000EP1060185A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof
12/20/2000EP1060184A1 Best's macular dystrophy gene
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000CN1277636A High efficiency vetroviral rectors that contain none of viral coding sequences
12/20/2000CN1277635A Nucleic acids having promoter activity and transgenic plants containing the same
12/20/2000CN1277634A New tissue-specific calpaines, their production and their use
12/20/2000CN1277633A Mutants of thyroid stimulating hormone and methods based thereon
12/20/2000CN1277632A Natural human antibody
12/20/2000CN1277631A Suspension packing cell lines for retrovirus vectors
12/20/2000CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
12/20/2000CN1277614A Mammaglobin a secreted mammary-specific breast cancer protein
12/20/2000CN1277358A Biological test reagent for monilia albicans infection and its preparation
12/20/2000CN1277262A Urokinase zymogen mutant
12/20/2000CN1277261A Animal's castration vaccine gene and gene engineering body
12/20/2000CN1277260A Human actin related protein subunit and its code sequence
12/20/2000CN1277259A Homologous protein of late embryo ample-protein and its code sequence
12/20/2000CN1277258A Mutation alph-amylase
12/20/2000CN1277208A New angio-auxin derivative protein and its code sequence
12/20/2000CN1277207A Phytase with heat tolerance
12/20/2000CN1277206A Purification technology for hepatitis B surface gene fusion antigen containing S-main protein and pre-S1-macroprotein
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/20/2000CN1059704C Anti-diseases perfume tobacco cultured by gene engineering method
12/20/2000CN1059703C Direct demonstration of human insulin precursor-gene in bacillus coli and after-processing method
12/20/2000CN1059599C 蛙病毒疫苗 Frog virus vaccine
12/19/2000US6162967 Positional cloning of soybean cyst nematode resistance genes
12/19/2000US6162966 Transgenic plant cell exhibiting reduced disproportionating enzyme activity due to presence of exogenous dna which deactivates the endogenous enzyme; increased phosphate content of starch
12/19/2000US6162965 Plant transformation methods
12/19/2000US6162964 Promoter which causes transcription in cells critical to pollen formation or function and a dna sequence encoding a gene product which converts nontoxic substance to cytotoxic one; simple and efficient production of stable hybrid seeds
12/19/2000US6162963 Generation of Xenogenetic antibodies
12/19/2000US6162909 Deprotection of RNA
12/19/2000US6162908 Polypeptide of human-origin hyaluronate synthetase and DNA encoding the same
12/19/2000US6162903 Immunoglobulin binding proteins derived from L protein and their uses
12/19/2000US6162902 Reactive to epitopes of human brain natriuretic peptide; rapid and sensitive quantification in plasma or serum
12/19/2000US6162900 Amino acid sequences of polypeptide which transports cadmium, iron(ii), cobalt, manganese, lead, mercury, and zinc; transgenic plants with increased metal uptake for use as nutrient supplements or removing toxic metals from soils
12/19/2000US6162898 Mutant Rev transdominant repressors of HIV replication
12/19/2000US6162897 17q-linked breast and ovarian cancer susceptibility gene
12/19/2000US6162896 Isolated polypeptide encoded by a defined nucleotide sequence; antitumor agents; wound healing agents; immunosuppressants; diagnosis and treatment of immune, reproductive, or central nervous system disorders
12/19/2000US6162796 Method for transferring genes to the heart using AAV vectors
12/19/2000US6162789 Frozen food product
12/19/2000US6162782 Detergent compositions containing cellulase compositions deficient in CBH I type components
12/19/2000US6162641 Nucleotide sequence derived from a promoter sequence and operably linked to a heterologous gene; for controlled gene expression
12/19/2000US6162640 Selected population of host cells and/or replicators which express a molecule that undergoes a desired interaction with a recognition sequence; for efficient and rational method of controlling evolution
12/19/2000US6162633 Process and kit for fragment cloning
12/19/2000US6162631 Retrovirus from the HIV group and its use (MVP-2901/94)
12/19/2000US6162630 Asp1
12/19/2000US6162628 Enzymatic polypeptide which retards or prevents degradation/aging of baked goods
12/19/2000US6162626 Thermostable glutamate dehydrogenase and process for producing the same
12/19/2000US6162619 Sensor histidine kinase of streptococcus pneumoniae
12/19/2000US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines
12/19/2000US6162617 Streptococcus pneumoniae gene sequence dnaG
12/19/2000US6162613 Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases
12/19/2000US6162612 Enzymatic polypeptide; for te detection of enzyme inhibitor which can be used to treat cancer, psoriasis and vascular system defects; anticarcinogenic agents
12/19/2000US6162605 Oligonucleotides for the isolation of target nucleotide sequences from microorganisms
12/19/2000US6162603 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
12/19/2000US6162461 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
12/19/2000US6162439 An isolated polypeptides derived from novel lentiviruses for the detection of aids
12/19/2000US6162435 A isolated protein for treating swine; a diagnostic test kit for detecting the presence of bacterial infection in swine herds
12/19/2000US6162433 A transformed cell which is an attenuated strain of its natural counterpart, can be engineered to express at least one antigen and at least one safe, selectable marker
12/19/2000US6162431 Serine/threonine protein kinase
12/19/2000US6162430 At least two different insecticide proteins provide synergistic control
12/19/2000US6161657 Mechanical lock with a cam-driven locking pawl
12/19/2000CA2203808C Hybrid adenovirus-aav virus and method of use thereof
12/19/2000CA2150232C A highly sensitive method for detecting environmental insults
12/19/2000CA2067244C Monoclonal antibody specific for iga receptor